Intellia Therapeutics stock surged Tuesday after the FDA aid it would allow the company to restart a gene-editing study.

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI ® (ublituximab-xiiy), to be presented at the Americas Committee for Treatment and ...

More than 1.2 million people in the UK have been warned not to drink two fruit juices as it could pose a serious risk to ...

Chronically high levels of insulin and inflammation are key features of obesity and metabolic syndrome, which mediate cancer ...

PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles ...

For decades, patients with inflammatory bowel disease have reported a familiar and frustrating pattern: periods of intense stress are often followed by worsening symptoms or full-blown disease flares.